• 1
  • 2

Vela Genomics for Powerful Next-Generation Sequencing (NGS) Clinical Reporting


TheraKey™ by Vela Genomics provides Accurate Clinical Interpretation and Reporting for high-throughput NGS somatic oncology testing. The powerful solution transforms rich genomics profiling data into clinically actionable outcomes. TheraKey™ is compatible with any NGS instrument to provide information beyond the standard reporting. It saves costs and accelerate TAT by saving time spent on manually researching and cross referencing all information from various database. We aim to assist clinicians in expanding their cancer patient’s treatment options, empowering precision medicine in healthcare.

Learn More About TheraKey™

TheraKey™ Interpretation Report for Accurate Matching of Patient-to-Treatments

 FDA Approved, Off-Label, Investigational Drugs
 Contraindicated Therapies by NCCN Guidelines®
 Matched Recruiting Clinical Trials Worldwide
 Reviewed by Certified Clinicians and Curation Scientists
Request Your Sample Report

It's Two Easy Steps

Get Started Now  


1. Sign Up for an Account

Click here to sign up for a Vela Genomics account. Variant Call File (.vcf) is needed to start the interpretation.


2. Receive TheraKey Report

Tailor care through personalised clinically actionable solutions. You will receive a notification email once the report is ready.

Get The Latest Updates on Vela Genomics